hit counter
BioLife Solutions, Inc. (BLFS) Stock News Sentiment & Price - Sentifly
BLFS - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



BioLife Solutions, Inc. (BLFS)

USA
Medical Instruments & Supplies
NASDAQ
BLFS Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
BLFS Latest news
PRNewsWire
Neutral
BioLife Solutions Announces Third Quarter 2021 Financial Results
2021-11-11 16:05

BOTHELL, Wash., Nov. 11, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced financial results for the three and nine months ended September 30, 2021.

PRNewsWire
Neutral
BioLife Solutions Announces Executive Management Changes
2021-11-04 16:05

BOTHELL, Wash., Nov. 4, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (the "Company") (Nasdaq: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced changes to its executive management team, effective immediately.

PRNewsWire
Neutral
BioLife Solutions to Report Third Quarter 2021 Financial Results and Provide Business Update on November 11, 2021
2021-11-04 08:03

BOTHELL, Wash., Nov. 4, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's third quarter 2021 financial results will be released after market close on Thursday, November 11 th.

Zacks Investment Research
Negative
Analysts Estimate BioLife Solutions, Inc. (BLFS) to Report a Decline in Earnings: What to Look Out for
2021-10-28 16:49

BioLife Solutions, Inc. (BLFS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRNewsWire
Neutral
Biolife Solutions Supports Biostorage Best Practices Through SciSafe's "Centers of Excellence" With New World-Class Facility in Amsterdam
2021-10-26 08:05

BOTHELL, Wash., Oct. 26, 2021 /PRNewswire/ -- Biolife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for cell and gene therapies ("CGT"), and its biological material storage brand SciSafe, a multi-facility provider of storage services to the CGT and broader biopharma market, today announced the opening of a new 40,000 square-foot biorepository Center of Excellence in Amsterdam, adjacent to the Schiphol Airport.

The Motley Fool
Positive
Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom
2021-10-15 06:50

This company is preserving biological material and can help your portfolio grow.

PRNewsWire
Neutral
BioLife Solutions Leverages Expanded Bioproduction Tools and Services Portfolio in Multipoint Engagement with Leading CAR T-Cell Developer
2021-10-04 08:00

BOTHELL, Wash., Oct. 4, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced a broad engagement with a leading cell therapy developer, wherein BioLife's CryoStor freeze media, evo cold chain management platform and SciSafe storage services with Stirling UltraCold freezers are all being utilized by this top 10 largest global pharmaceutical company to support the anticipated regulatory approval and commercial launch of a new CAR T-cell therapy.

Benzinga
Positive
Notable Biolife Solutions Insider Trades $971 Thousand In Company Stock
2021-09-23 11:01

Aby Mathew, Exec VP And Chief Scientific Off at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on September 22, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Aby Mathew exercised options to purchase 20,000 Biolife Solutions shares at a price of $1.64 per share for a total of $32,800 on September 22.

PRNewsWire
Neutral
BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors
2021-09-20 08:00

BOTHELL, Wash., Sept. 20, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that Joydeep Goswami, Chief Strategy and Corporate Development Officer at Illumina, will join its board of directors on October 1, 2021.

PRNewsWire
Neutral
BioLife Solutions Announces CFO Retirement
2021-09-15 08:00

BOTHELL, Wash., Sept. 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that Roderick de Greef, Chief Financial Officer, plans to retire on December 31, 2021 after a distinguished career with the Company.

Loading more news...